Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 16

1.

A DNA hypermethylation module for the stem/progenitor cell signature of cancer.

Easwaran H, Johnstone SE, Van Neste L, Ohm J, Mosbruger T, Wang Q, Aryee MJ, Joyce P, Ahuja N, Weisenberger D, Collisson E, Zhu J, Yegnasubramanian S, Matsui W, Baylin SB.

Genome Res. 2012 May;22(5):837-49. doi: 10.1101/gr.131169.111. Epub 2012 Mar 5.

2.

Epigenetic states in stem cells.

Collas P.

Biochim Biophys Acta. 2009 Sep;1790(9):900-5. doi: 10.1016/j.bbagen.2008.10.006. Epub 2008 Oct 25. Review.

PMID:
19013220
3.

Role of the polycomb group proteins in hematopoietic stem cells.

Konuma T, Oguro H, Iwama A.

Dev Growth Differ. 2010 Aug;52(6):505-16. doi: 10.1111/j.1440-169X.2010.01191.x. Review.

PMID:
20646023
4.

Identification of driver and passenger DNA methylation in cancer by epigenomic analysis.

Kalari S, Pfeifer GP.

Adv Genet. 2010;70:277-308. doi: 10.1016/B978-0-12-380866-0.60010-1. Review.

5.

Polycomb complexes in stem cells and embryonic development.

Aloia L, Di Stefano B, Di Croce L.

Development. 2013 Jun;140(12):2525-34. doi: 10.1242/dev.091553. Review.

6.

Concise review: roles of polycomb group proteins in development and disease: a stem cell perspective.

Rajasekhar VK, Begemann M.

Stem Cells. 2007 Oct;25(10):2498-510. Epub 2007 Jun 28. Review.

7.

Chromatin remodeling and bivalent histone modifications in embryonic stem cells.

Harikumar A, Meshorer E.

EMBO Rep. 2015 Dec;16(12):1609-19. doi: 10.15252/embr.201541011. Epub 2015 Nov 9. Review.

8.

Epigenetic plasticity of chromatin in embryonic and hematopoietic stem/progenitor cells: therapeutic potential of cell reprogramming.

Zardo G, Cimino G, Nervi C.

Leukemia. 2008 Aug;22(8):1503-18. doi: 10.1038/leu.2008.141. Epub 2008 Jun 12. Review.

PMID:
18548105
9.

Stem cells, cancer, and epigenetics.

Baylin SB.

StemBook [Internet]. Cambridge (MA): Harvard Stem Cell Institute; 2008-.
2009 Oct 31.

10.

Programming the genome in embryonic and somatic stem cells.

Collas P, Noer A, Timoskainen S.

J Cell Mol Med. 2007 Jul-Aug;11(4):602-20. Review.

11.

Mutations in regulators of the epigenome and their connections to global chromatin patterns in cancer.

Plass C, Pfister SM, Lindroth AM, Bogatyrova O, Claus R, Lichter P.

Nat Rev Genet. 2013 Nov;14(11):765-80. doi: 10.1038/nrg3554. Epub 2013 Oct 9. Review.

PMID:
24105274
12.

Polycomb group proteins: multi-faceted regulators of somatic stem cells and cancer.

Sauvageau M, Sauvageau G.

Cell Stem Cell. 2010 Sep 3;7(3):299-313. doi: 10.1016/j.stem.2010.08.002. Review.

13.

The role of Polycomb in stem cell genome architecture.

Mas G, Di Croce L.

Curr Opin Cell Biol. 2016 Dec;43:87-95. doi: 10.1016/j.ceb.2016.09.006. Epub 2016 Sep 28. Review.

PMID:
27690123
14.

Polycomb and the emerging epigenetics of pancreatic cancer.

Grzenda A, Ordog T, Urrutia R.

J Gastrointest Cancer. 2011 Jun;42(2):100-11. doi: 10.1007/s12029-011-9262-4. Review.

15.

[Disease and epigenome analysis].

Toyota M, Suzuki H, Kai M.

Seikagaku. 2010 Aug;82(8):693-701. Review. Japanese. No abstract available.

PMID:
20857683
16.

Role of epigenetic modulation in cancer stem cell fate.

Deshmukh A, Binju M, Arfuso F, Newsholme P, Dharmarajan A.

Int J Biochem Cell Biol. 2017 Jul 12;90:9-16. doi: 10.1016/j.biocel.2017.07.003. [Epub ahead of print] Review.

PMID:
28711634

Supplemental Content

Support Center